| Cancer type |
Drugs used |
| Breast |
Docetaxel, epirubicin, cyclophosphamide, methotrexate,
5-fluorouracil, trastuzumab, vinorelbine, capecitabine, paclitaxol |
| Lower gastrointestinal (colorectal) |
5-Fluorouracil, capecitabine, oxaliplatin, irinotecan,
cetuximab |
| Upper gastrointestinal (oesophagus, stomach, and pancreas) |
5-Fluorouracil, capecitabine, epirubicin, cisplatin
gemcitabine, cyclophosphamide, irinotecan, erlotinib |
| Lung |
Cisplatin, carboplatin, paclitaxel, docetaxel, vinorelbine,
gemcitabine, erlotinib |
| Ovary |
Cisplatin, carboplatin, paclitaxel |
| Germ cell tumour |
Cisplatin, carboplatin, etoposide, bleomycin, paclitaxel,
gemcitabine, ifosphamide |
| Prostate |
Docetaxel, mitoxantrone |
| Bladder |
Cisplatin, methotrexate, vinblastine, carboplatin,
gemcitabine |
| Non-Hodgkin’s lymphoma |
Cyclophosphamide, adriamycin, vincristine, prednisolone,
rituximab, chlorambucil, etoposide |
| Hodgkin’s disease |
Adriamycin, bleomycin, vincristine, DTIC |
| Head and neck cancers |
Cisplatin, 5-fluorouracil, cetuximab |
